NEW YORK (GenomeWeb) – DuPont Diagnostics today announced an exclusive distribution agreement granting VWR rights in the US to sell the DuPont BAX System Q7 instrument, assays, and related products. 

The BAX platform is a PCR-based pathogen detection technology for the food industry. It provides automated testing for foodborne pathogens, spoilage organisms, and other microbes in raw ingredients, finished products, and manufacturing environments, DuPont Diagnostics, part of DuPont Nutrition & Health, said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Sponsored by

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.